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Abstract
Background: Genome-wide association studies (GWAS) in White Europeans have shown that genetic variation 
rs10830963 in melatonin receptor 1B gene (MTNR1B) is associated with fasting glucose and type 2 diabetes, which has 
also been replicated in several Asian populations. As a variant in the gene involved in the regulation of circadian 
rhythms, the effect of the variant on sleep status remains unknown. This study aimed to investigate the effects of 
MTNR1B rs10830963 on fasting glucose, type 2 diabetes and sleep status in Chinese Hans.
Methods: MTNR1B rs10830963 was genotyped in a population-based cohort including 3,210 unrelated Chinese Hans 
from Beijing and Shanghai, and tested for associations with risk of type 2 diabetes, diabetes-related traits and sleep 
status.
Results: We confirmed the associations of MTNR1B rs10830963 with fasting glucose (beta = 0.11 mmol/l, 95%CI [0.03, 
0.18], P = 0.005), glycated hemoglobin (HbA1c) (beta = 0.07%, 95%CI [0.02,0.12], P = 0.004) and homeostasis model 
assessment of beta-cell function (HOMA-B) (beta = -5.01%, 95%CI [-8.24,-1.77], P = 0.003) in the Shanghai, but not in the 
Beijing subpopulation (P ≥ 0.58). The effect size of MTNR1B rs10830963 on fasting glucose in Shanghai Chinese Hans 
was comparable to that reported from other Asian populations. We found no evidence of associations with type 2 
diabetes (OR 1.05 [0.90-1.23], P = 0.54), homeostasis model assessment of insulin sensitivity (HOMA-S) (P = 0.86) or sleep 
status (P ≥ 0.44).
Conclusions: A common variant in MTNR1B was associated with fasting glucose, HbA1C and HOMA-B but not with 
sleep status in Chinese Hans from Shanghai, strengthening the role of MTNR1B rs10830963 in fasting glycemia and 
impaired beta-cell function.
Background
There is growing evidence suggesting that circadian
rhythms are closely linked to metabolic regulation, and
dysregulation of circadian rhythms may increase diabetes
risk [1]. Consistently, melatonin, a major regulator of cir-
cadian rhythms, has been shown to influence both insulin
secretion and glucose homeostasis, and both melatonin
secretion and circadian rhythm are impaired in type 2
diabetes patients [2]. It is therefore likely that melatonin
may provide a link between circadian rhythms and glu-
cose homeostasis.
The melatonin effects on sleep and circadian phase are
mainly mediated by activation of its two receptors: mela-
tonin receptor 1A (MT1) and melatonin receptor 1B
(MT2) [3]. They are encoded by MTNR1A and MTNR1B,
respectively, and both expressed in human pancreatic
islets [4]. Receptor MT1 is mainly expressed in alpha cells
while MT2 is predominantly expressed in beta cells and
upregulated in pancreatic islets of type 2 diabetic patients
[2,4,5], suggesting that MT2 receptor may play a role in
insulin secretion and type 2 diabetes.
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Page 2 of 7Recently, several large-scale genome-wide association
analyses using data from more than ten genome-wide
association scans identified common variants in or near
the MTNR1B gene to be robustly associated with fasting
glucose levels in populations of Europeans descent [6-8],
with SNP rs10830963 showing the most significant asso-
ciation signal [7]. Several replication studies in European
[5,9-11] and Asian populations [12,13] showed reproduc-
ible associations for MTNR1B rs10830963. A case-con-
trol study including 1165 case and 1105 control of
Chinese Hans from Shanghai [13] confirmed the associa-
tions of MTNR1B rs10830963 with increased risk of type
2 diabetes and increasing fasting glucose, while another
study in general Japanese and Sri Lankan populations [12]
reported association between the variant and fasting glu-
cose with effect sizes similar to those observed in Chinese
Hans [13]. Further analyses showed that the MTNR1B
variants were also significantly associated with increased
risk of type 2 diabetes, and with increased fraction of gly-
cated hemoglobin (HbA1C), reduced beta-cell function as
estimated by homeostasis model assessment of beta-cell
function (HOMA-B), but not with fasting insulin level or
insulin sensitivity [6,7]. The risk G-allele of rs10830963
also predicted future type 2 diabetes in both the MPP (the
Malmö Prevention Project) and Botnia prospective stud-
ies [5]. Furthermore, nondiabetic individuals carrying the
risk G-allele showed increased expression of MTNR1B in
pancreatic islets [5] and the MTNR1B risk G-allele has
been suggested to increase risk of impaired fasting glyce-
mia and type 2 diabetes through impaired insulin secre-
tion [5,9,11,14]. These observations provide strong
evidence for a role of MTNR1B in glucose homeostasis
and type 2 diabetes.
The aim of this study was to examine whether the asso-
ciation previously reported for rs10830963 which located
in the only intron of MTNR1B could be replicated in a
population-based cohort including 3,210 unrelated Chi-
nese Hans from Shanghai and Beijing. We also tested for
a role of MTNR1B rs10830963 in sleep duration and qual-
ity in this population.
Methods
Study participants
The sample consists of 3,210 unrelated individuals (1,423
men and 1,787 women) from the Study on Nutrition and
Health of Aging Population in China, a population-based
study of non-institutionalized Chinese Hans aged 50 to
70 years from Beijing and Shanghai. The design of this
study have been previously described in detail [15]. Type
2 diabetes was defined as fasting plasma glucose ≥7.0
mmol/L and/or previously diagnosed diabetic (424 type 2
diabetes: 37% screen-detected, 63% previously diag-
nosed). Normal fasting glucose (NFG) was defined as
fasting glucose <5.6 mmol/L (100 mg/dL). Homeostasis
model assessment of insulin sensitivity (HOMA-S) and
beta-cell function (HOMA-B) was estimated by Levy's
computer model, and BMI was calculated as weight (kg)/
height2 (m2). A questionnaire of six questions was used to
evaluate sleep quantity and quality, including sleep dura-
tion and self-reported sleep disturbance during the past
month, as well as siesta frequency. Informed written con-
sent was obtained from the participants and the Institu-
tional Review Board of the Institute for Nutritional
Sciences approved the study protocol.
Genotyping
The SNP rs10830963 was genotyped by the GenomeLab
SNPstream Genotyping System (Beckman Coulter) with
98.1% genotyping success rates. The concordance rate
was 99.2% based on 12% duplicate samples (n = 384). The
genotypic distributions were similar between Beijing and
Shanghai (P = 0.11) and were in Hardy-Weinberg equilib-
rium (P = 0.28).
Statistical methods
Generalized linear regression was used for the associa-
tions with diabetes-related quantitative traits and gene-
geographical regions (Beijing/Shanghai) or gene-sleep
status interactions in which participants with known dia-
betes or receiving glucose-lowering treatment (n = 276)
were excluded. Logistic regression was applied to test the
associations of rs10830963 with type 2 diabetes and sleep
disorder. All the analyses above assumed an additive
effect of the risk allele adjusting for age, sex, BMI and
sleep status (where appropriate). The associations with
sleep duration, siesta frequency and self-reported sleep
disorder were carried out using nonparametric test
(Kruskal-Wallis), χ2 test and logistic regression, respec-
tively. Given the significant interactions between the gen-
otypes and the geographical regions on fasting glucose
and HOMA-B, association studies were performed in
Beijing and Shanghai subpopulations separately. We con-
ducted meta-analyses applying Cochran Q test in Stata to
evaluate the combined effect sizes of subpopulations and
the heterogeneity of effect size across different ethnic
populations. The meta-analyses were carried out using
inverse variance weighting and random model. HOMA-S
was log-transformed before analyses. Power calculations
were assessed using Quanto software http://
hydra.usc.edu/gxe. Statistical analyses were conducted
using R (version 2.6.1) and Stata 9.2 (StataCorp, college
station, Texas). Two-side P values < 0.05 were considered
to be statistically significant.
Results
The risk G allele frequency of MTNR1B rs10830963 in
this Chinese population (42.3%, Beijing/Shanghai: 41.2%/
43.5%) was comparable to that reported by the Interna-
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Page 3 of 7tional HapMap CHB sample (47.8%), and higher than that
for the CEU sample (30%). The characteristics of the
study participants were summarized in Table 1.
Consistent with the previous findings in White Europe-
ans [5,7,11,14] and Asian populations [12,13], the
MTNR1B rs10830963 G allele showed significant associa-
tions with increased levels of fasting glucose (beta = 0.11
mmol/l, 95%CI [0.03, 0.18], P = 0.005) and HbA1C (beta =
0.07%, 95%CI [0.02,0.12], P = 0.004) and with decreased
HOMA-B values (beta = -5.01%, 95%CI [-8.24,-1.77], P =
0.003) in the Shanghai subpopulation, but not in the Bei-
jing subpopulation (All traits P ≥ 0.58) (P for interaction =
0.05 for fasting glucose, 0.09 for HbA1C, 0.01 for HOMA-
B) (Table 2). The observed effect size on fasting glucose in
Shanghai participants of this study was similar to that
reported for Shanghai Chinese Hans by Ronn et al. [13]
(P for heterogeneity = 0.33). Meta-analyses of our data in
Chinese and the published data, including all studies in
White Europeans [5,7,9-11] and Asians [12,13], showed
significant heterogeneity in effect size on fasting glucose
levels among white Europeans (P for heterogeneity = 7.7
× 10-4) but not among Asian populations (P for heteroge-
neity = 0.37). The overall effect size in Asians (0.06
mmol/l/per allele) tended (P for heterogeneity = 0.06) to
be smaller than that in White Europeans (0.08 mmol/l/
per allele) (Figure 1)."
We observed no significant associations with log-trans-
formed HOMA-S (P ≥ 0.66) and type 2 diabetes (ORs:
0.99-1.14, P ≥ 0.31) either in Shanghai and Beijing sub-
populations or in the whole population. No significant
associations of MTNR1B rs10830963 with sleep duration,
siesta frequency or sleep disorder were found in either
Beijing or Shanghai subpopulations (P ≥ 0.44) (Table 3).
Moreover, further adjustment for sleep duration (Table 2,
model 2) or self-reported sleep disorder (Table 2, model
3) did not materially change the associations for diabetes-
related quantitative traits in either Shanghai or Beijing
subpopulation, and no significant gene-sleep status inter-
action (P for interaction ≥ 0.22) was observed (Table 2).
Discussion
In this population-based sample of Chinese Hans, we
confirmed that MTNR1B rs10830963 G allele was signifi-
cantly associated with increased fasting plasma glucose
and HbA1C in Shanghai, but not in Beijing Hans. These
findings in the Shanghai subpopulation were consistent
with those of previous studies [5,7,11-14] and further
highlight the importance of MTNR1B rs10830963 variant
for insulin secretion. Significant heterogeneity in effect
size on fasting glucose was observed only among White
Europeans, but not among Asians in meta-analyses with
data from our study and the previously reported. The
overall effect size on fasting glucose among Asians
tended to be smaller than that in white Europeans. How-
ever, this result should be interpreted with caution since
the heterogeneity observed in White Europeans may
introduce bias to the comparison among Chinese and
European overall effects. More studies are required to
draw a firm conclusion.
Table 1: Characteristics of the study population
Beijing Shanghai Total population P
N (%male) 1574 (45.2) 1636 (43.5) 3210 (44.3)
Age (years) 58.3 ± 5.9 58.9 ± 6.0 58.6 ± 6.0 0.0095
BMI (kg/m2) 25.1 (22.8-27.4) 23.5 (21.3-25.9) 24.2 (22.0-26.6) < 0.0001
Current smoker (%) 499 (31.7) 403 (24.7) 902 (28.1) < 0.0001
Current drinker (%) 584 (37.1) 327 (20.0) 911 (28.4) < 0.0001
Physical activity, (MET-h/wk) 49.1 (23.1-76.4) 39.6 (23.1-65.5) 46.2 (23.1-69.3) < 0.0001
Sleep duration, hour 8.0 (7.0-8.5) 7.5 (6.5-8.0) 8.0 (7.0-8.0) < 0.0001
Self-reported sleep disorder (%) 362 (22.97) 251 (15.36) 613 (19.10) < 0.0001
Fasting glucose (mmol/l) 6.16 ± 1.96 5.53 ± 1.42 5.84 ± 1.74 < 0.0001
HbA1C (%) 6.08 ± 1.22 5.90 ± 0.96 5.99 ± 1.10 < 0.0001
HOMA-B (%) 100.1 ± 44.9 120.0 ± 46.9 110.3 ± 47.0 < 0.0001
HOMA-S (%) 64.0 (47.3-89.5) 63.5 (46.9-85.1) 63.7 (47.1-86.9) 0.05
Diabetes (%) 272 (17.3) 152 (9.3) 424 (13.2) < 0.0001
Obesity (%) 320 (20.3) 154 (9.4) 474 (14.8) < 0.0001
Hypertension (%) 978 (62.1) 803 (49.1) 1781 (55.5) < 0.0001
Data are mean ± SD, median (inter-quartile range) or n (%). P represents significance of the differences between Beijing and Shanghai 
subpopulations.
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between Beijing and Shanghai, we compared their differ-
ence in allele frequencies, prevalence of type 2 diabetes
and environmental/lifestyle factors. Yet, the G-allele fre-
quencies and genotype distributions of the MTNR1B
rs10830963 were similar between Beijing and Shanghai
subpopulations. Given that individuals from Beijing have
a higher prevalence of type 2 diabetes than their Shanghai
counterparts and also live a less healthy lifestyle (Table 1),
the discrepancies observed between Beijing and Shanghai
participants could possibly be attributed to unmeasured
environmental/lifestyle factors that may have masked the
effect of the MTNR1B variant.
Although we failed to replicate the association for type
2 diabetes risk in this study, the observed effect size was
within the 95% confidence interval of the effect size
observed for White Europeans [6,7]. Assuming an addi-
tive model and a minor allele frequency of 42.3%, we had
Figure 1 Association of rs10830963 with fasting glucose under an additive model using meta-analyses. The data in Asian populations are from 
the studies in Chinese (Chinese Hans from SH 1 [13], Chinese Hans from SH2 and BJ in this population), Japanese [12] and Sri Lankan [12], and data in 
Europeans are from studies of CoLaus [7], deCODE [7], DGI [7], Framingham [7], FUSION [7], NFBC1966 [7], NTR/NESDA [7], Rotterdam [7], Sardinia [7], 
TwinUK [7], DESIR [11], Haguenau [11], Inter99 [11], NFBC86 [11], Botnia PPP [5], Botnia prospective [5], Helsinki Birth Cohort [5], METSIM [5], New Hoorn 
Study [10] and RISC [9]. The black circles and horizontal lines represent the point estimated beta and 95% CI for of each study, respectively. The overall 
95% CI for the meta-analyses is represented by diamond. SH, Shanghai; BJ, Beijing.
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Table 2: Associations of rs10830963 with fasting glucose, HbA1C, HOMA-B and HOMA-S.
MTNR1B rs10830963 Beijing (1389) Shanghai (1497) Total population (2886) P for Interaction
beta (SE) Padd beta (SE) Padd beta (SE) Padd SNP × Region SNP × Sleep duration SNP × Sleep disorder
Glucose(mmol/l)
Model 1 -0.03 (0.06) 0.59 0.11 (0.04) 0.005 0.04 (0.07) 0.51 0.05 0.35 0.48
Model 2 -0.03 (0.05) 0.58 0.11 (0.04) 0.005 0.04 (0.07) 0.52
Model 3 -0.03 (0.06) 0.59 0.11 (0.04) 0.005 0.04 (0.07) 0.51
HbA1C (%)
Model 1 -0.003 (0.04) 0.93 0.07 (0.02) 0.004 0.04 (0.04) 0.30 0.09 0.52 0.22
Model 2 -0.004 (0.04) 0.92 0.07 (0.03) 0.004 0.04 (0.04) 0.31
Model 3 -0.004 (0.04) 0.93 0.07 (0.03) 0.004 0.04 (0.04) 0.30
HOMA-B (%)
Model 1 0.88 (1.58) 0.58 -5.01 (1.65) 0.003 -2.04 (2.94) 0.49 0.01 0.75 0.34
Model 2 0.91 (1.57) 0.56 -5.01 (1.65) 0.003 -2.02 (2.96) 0.49
Model 3 0.88 (1.58) 0.58 -5.01 (1.65) 0.003 -2.04 (2.94) 0.49
Log-transformed HOMA-S (%)
Model 1 -0.004 (0.02) 0.82 0.008 (0.02) 0.66 0.002 (0.01) 0.86 0.65 0.31 0.73
Model 2 -0.005 (0.02) 0.82 0.008 (0.02) 0.66 0.002 (0.01) 0.86
Model 3 -0.004 (0.02) 0.82 0.008 (0.02) 0.66 0.002 (0.01) 0.86
Participants previously diagnosed with type 2 diabetes or receiving glucose-lowering treatment (n = 264) were excluded from the analyses. HOMA-S values were log-transformed before analyses. 
P values and beta (SE) for Beijing and Shanghai subpopulations were calculated using linear regression model assuming an additive model. The combined P values and beta (SE) were calculated in 
meta-analyses using random model.
Model 1: Adjusted for age, sex and BMI.
Model 2: Adjusted variables in model 1 plus sleep duration.
Model 3: Adjusted variables in model 1 plus self-reported sleep disorder.
P values for interaction were tested in linear regression model using terms of SNP × Region (Beijing/Shanghai), SNP × Sleep duration or SNP × Sleep disorder.
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Table 3: Association of rs10830963 with sleep status
MTNR1B rs10830963 Beijing Shanghai
CC CG GG P CC CG GG P
N (%male)a 539 (46.9) 747 (45.0) 265 (42.3) 0.45 500 (44.6) 807 (42.4) 292 (45.2) 0.61
Age (years)b 58.5 (6.0) 58.2 (5.8) 58.5 (6.1) 0.55 58.8 (6.2) 58.8 (5.9) 59.3 (6.1) 0.49
BMI (kg/m2)b 25.4 (3.7) 25.2 (3.6) 25.0 (3.7) 0.36 23.7 (3.3) 23.5 (3.3) 23.8 (3.3) 0.51
Sleep duration (hour)c 8.0 (7.0-8.3) 8.0 (7.0-8.5) 8.0 (7.0-8.0) 0.95 7.5 (6.5-8.0) 7.5 (6.0-8.0) 7.8 (6.5-8.0) 0.44
Siesta frequency (%)a
Never 157 (29.1) 192 (25.7) 73 (27.6) 0.92 262 (52.4) 402 (49.8) 155 (53.1) 0.81
Occasional 87 (16.1) 122 (16.3) 43 (16.2) 92 (18.4) 171 (21.2) 54 (18.5)
Regularly during summer 63 (11.7) 96 (12.9) 32 (12.1) 62 (12.4) 102 (12.6) 40 (13.7)
Regularly during the year 232 (43.1) 337 (45.1) 117 (44.1) 84 (16.8) 132 (16.4) 43 (14.7)
Self-reported sleep disorder (%)a 127 (23.6) 164 (22.0) 67 (25.3) 0.50 77 (15.4) 126 (15.6) 42 (17.1) 0.88
Per-allele effect on self-reported 
sleep disorder (OR [95% CI])d
1.00 (0.85-1.19) 0.96 0.97 (0.79-1.18) 0.75
Data are mean ± SD, median (inter-quartile range), n (%), or odd ratio (95%CI).
P values were calculated using χ2 test a, linear regression model b, Kruskal-Wallis test c, or logistic regression model under an additive model adjusting for age, sex and BMI.
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of 1.09 [7] for type 2 diabetes and beta value of 0.072
mmol/l [7] for fasting glucose at P < 0.05. Thus, absence
of association with type 2 diabetes and related quantita-
tive traits in our study could be due to insufficient power.
Considering the important role of melatonin in modu-
lating circadian rhythms and sleep duration, the associa-
tion of MTNR1B rs10830963 with fasting plasma glucose
and insulin secretion might be partially explained by the
disrupted sleep and circadian rhythms in the carriers of
risk G allele. However, our study provided no evidence for
the association with sleep duration, siesta frequencies or
self-reported sleep disorder. Also, further adjustment for
these sleep variables did not materially change the associ-
ations with HOMA-B, fasting plasma glucose and HbA1C.
Our study had 80% power to detect odd ratio (OR) ≥ 1.27,
1.32 and 1.20 for self-reported sleep disorder at a signifi-
cance of 5% in Beijing, Shanghai subpopulation and in
whole population, respectively. Since the effect size of
this variant on sleep status is largely unknown, more
studies with larger sample size may be required before the
conclusion that sleep duration or quality has no impact
on the association between MTNR1B rs10830963 and
diabetes-related traits can be drawn.
Conclusions
We confirmed the associations of MTNR1B rs10830963
with fasting glucose, HbA1C and HOMA-B in Chinese
Hans from Shanghai. These associations were not
affected by sleep duration or quality, but more studies
with larger sample size are needed to verify this.
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